Title : Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib.

Pub. Date : 2012 Apr

PMID : 21359953

1 Functional Relationships(s)
Compound Name
Protein Name
1 The combination of lapatinib and nab-paclitaxel was well tolerated and provided good efficacy in women with HER2 positive breast cancer. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens